Analyst Ratings for Conatus Pharmaceuticals (CNAT)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4.3 / 10 Percentile Rank: 36%
Rating Score: 4.3 / 10 Percentile Rank: 36%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/26/2019 | Roth/MKM | Yasmeen Rahimi | Downgrade | Neutral (Buy) |
1.70 (N/A) |
1.28 (0.56) |
-56.25% | Details |
3/22/2019 | H.C. Wainwright | Ed Arce | Downgrade | Neutral (Buy) |
1.50 (8.00) |
2.88 (0.56) |
-80.56% | Details |